Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
A Bapsi Chakravarthy, MD, Vanderbilt-Ingram Cancer Center
ClinicalTrials.gov Identifier:
NCT00897793
First received: May 9, 2009
Last updated: April 10, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)